Otsuka America Pharmaceutical
GPTKB entity
Properties (48)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Avanir_Pharmaceuticals
|
| gptkbp:awards |
Best Places to Work
Pharmaceutical_Research_and_Manufacturers_of_America_(PhRMA)_member |
| gptkbp:clinicalTrials |
ongoing
completed planned |
| gptkbp:communityInvolvement |
educational programs
patient advocacy research funding volunteer programs healthcare_initiatives |
| gptkbp:employeeCount |
approximately 1,000
|
| gptkbp:focusArea |
metabolic disorders
oncology central nervous system disorders cardiovascular diseases infectious diseases |
| gptkbp:founded |
1986
|
| gptkbp:headquarters |
gptkb:Princeton,_New_Jersey
|
| https://www.w3.org/2000/01/rdf-schema#label |
Otsuka America Pharmaceutical
|
| gptkbp:operatesIn |
gptkb:United_States
|
| gptkbp:parentCompany |
gptkb:Otsuka_Pharmaceutical_Co.,_Ltd.
|
| gptkbp:partnerships |
gptkb:Mitsubishi_Tanabe_Pharma_Corporation
gptkb:Bristol-Myers_Squibb gptkb:Helsinn_Healthcare |
| gptkbp:products |
gptkb:Samsca
gptkb:Rexulti Aripiprazole Brexpiprazole Abilify Tolvaptan Vraylar Cariprazine |
| gptkbp:regulatoryCompliance |
FDA_approved
EMA_approved |
| gptkbp:researchFocus |
neurology
rare diseases neuroscience psychiatry pain management |
| gptkbp:subsidiary |
gptkb:Otsuka_Pharmaceutical_Co.,_Ltd.
|
| gptkbp:sustainabilityInitiatives |
community engagement
energy efficiency waste reduction sustainable sourcing environmental responsibility |
| gptkbp:website |
www.otsuka-us.com
|